Go offline with the Player FM app!
Precision Drug Delivery with Ampersand Biomedicines' Jason Gardner, D.Phil.
Manage episode 411308716 series 2739469
We love to hear from our listeners. Send us a message.
Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with the Flagship Pioneering-backed Ampersand, he's putting all those hard-fought lessons to good use. On this episode of the Business of Biotech -- the final (finally!) of several recorded at the JPM Healthcare Conference in January -- Gardner shares how and why he's applying his experience to the buildout of a precision medicine platform company, his thoughts on how big data and AI are influencing the precision medicine space and putting the "tech" in "techbio," his company's acquisition strategy, most recently demonstrated by Ampersand's acquisition of AbCheck, why "paranoid optimism" is central to his company's culture, and much, much more.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Chapters
1. Leadership & Business Development in Biotech (00:00:00)
2. Building a Platform Company (00:12:56)
3. Advancing Biotech Through Computational Technology (00:23:15)
4. Advancing Medical Technology With Collaborations (00:32:08)
5. Navigating Acquisition and Innovation in Biotech (00:40:59)
6. Business of Bioprocess Subscribers Interview (00:48:45)
215 episodes
Manage episode 411308716 series 2739469
We love to hear from our listeners. Send us a message.
Ampersand Biomedicines CEO Jason Gardner, D.Phil. first took the leap from a global pharmaceutical giant to a startup at the forefront of transplant medicine innovation. Since that time, he's seen most of the ups and the downs that come with biotech leadership, and in his latest venture with the Flagship Pioneering-backed Ampersand, he's putting all those hard-fought lessons to good use. On this episode of the Business of Biotech -- the final (finally!) of several recorded at the JPM Healthcare Conference in January -- Gardner shares how and why he's applying his experience to the buildout of a precision medicine platform company, his thoughts on how big data and AI are influencing the precision medicine space and putting the "tech" in "techbio," his company's acquisition strategy, most recently demonstrated by Ampersand's acquisition of AbCheck, why "paranoid optimism" is central to his company's culture, and much, much more.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Chapters
1. Leadership & Business Development in Biotech (00:00:00)
2. Building a Platform Company (00:12:56)
3. Advancing Biotech Through Computational Technology (00:23:15)
4. Advancing Medical Technology With Collaborations (00:32:08)
5. Navigating Acquisition and Innovation in Biotech (00:40:59)
6. Business of Bioprocess Subscribers Interview (00:48:45)
215 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.